While HDACs promote survival and inhibit various cell death mechanisms, inhibition of HDAC enzymes was reportedly pro-apoptotic and re-sensitized drug-resistant BRAF-mutant cancers to BRAF inhibitor and/or MEK inhibitor therapy. The gene discussed is HDAC9; the disease is cancer.